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The Autoantigen in Anti-p200 Pemphigoid Is
Synthesized by Keratinocytes and Fibroblasts
and Is Distinct from Nidogen-2
Silke C. Hofmann1, Ursula Voith1, Takako Sasaki2, Ralph M. Tru¨eb3, Roswitha Nischt4 and
Leena Bruckner-Tuderman1
Anti-p200 pemphigoid is a subepidermal immunobullous disorder associated with tissue-bound and circulating
autoantibodies reactive with a 200 kDa protein on the dermal side of salt-split-skin. The autoantigen, named
p200, is a non-collagenous glycoprotein located at the lamina lucida–lamina densa border of the epidermal
basement membrane. However, its identity and cellular origin remain elusive. Here, we used biochemical and
genetic approaches to characterize the autoantibody reactivity in three new patients with anti-p200
pemphigoid. We show that the target antigen p200 is synthesized by both keratinocytes and fibroblasts, is
disulfide-bonded, and participates in calcium-dependent molecular interactions. Lack of collagen XVII (BP 180),
collagen VII, or laminin 332 (laminin 5) from the dermal–epidermal junction does not destabilize p200.
Colocalization within the basement membrane zone and an identical molecular weight suggested nidogen-2 as
candidate autoantigen in anti-p200 pemphigoid, but biochemical analysis demonstrated that p200 is distinct
from nidogen-2. In conclusion, the results define further the biochemical characteristics of p200 and
demonstrate its in vitro-synthesis by keratinocytes and fibroblasts, thus providing a basis for identification and
further characterization of this autoantigen.
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INTRODUCTION
In subepidermal immunobullous diseases, binding of auto-
antibodies to structural molecules of the cutaneous basement
membrane zone results in impaired epidermal–dermal adhe-
sion (Yancey, 2005; Fassihi et al., 2006). Autoantibodies in
bullous pemphigoid (BP), the most frequent autoimmune
bullous disorder, target the hemidesmosomal components
collagen XVII (BP180) and BP230 (Hofmann et al., 2002; Van
den Bergh and Giudice, 2003). Other constituents of the
cutaneous basement membrane zone, such as laminin 332
(laminin 5), a6b4-integrin, and collagen VII, the major
component of anchoring fibrils, represent autoantigens of
mucous membrane pemphigoid and epidermolysis bullosa
acquisita (Hertl, 2000; McMillan et al., 2003). In 1996, anti-
p200 pemphigoid, a novel subepidermal immunobullous
disorder with circulating IgG4-antibodies directed against a
200 kDa protein of the dermis was first described (Chen et al.,
1996; Zillikens et al., 1996). The clinical spectrum can be
extremely variable with regard to morphology and extent
(Mascaro et al., 2000; Watanabe et al., 2002; Dilling et al.,
2007), but 2D-gel electrophoresis of dermal extracts demon-
strated that multiple anti-p200 sera recognized an identical
200 kDa protein, named p200 (Shimanovich et al., 2003).
Ultrastructural studies localized p200 to the lamina
lucida–lamina densa interface (Egan et al., 2002) and
biochemical characterization of dermal extracts demons-
trated that p200 is an acidic, non-collagenous, N-glycosy-
lated protein (Shimanovich et al., 2003). Based on these
features and on immunofluorescence (IF) and immunoblot
studies, it was predicted that the target is distinct from all
major autoantigens of the dermal–epidermal junction (Kawa-
hara et al., 2000; Mascaro et al., 2000; Zillikens et al., 2000;
Liu et al., 2003). However, low concentration and poor
solubility of p200 have hampered molecular identification
with a variety of methods, including N-terminal sequencing
and mass spectrometry (Zillikens et al., 1996; Shimanovich
et al., 2003). Therefore, the cellular origin and the identity of
p200 have yet to be elucidated.
An alternative approach is to test candidate molecules
with corresponding biochemical and localization character-
istics for reactivity with anti-p200 pemphigoid sera. One such
candidate is nidogen-2, a 200 kDa basement membrane
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protein that – via interaction with collagen I, collagen IV, and
perlecan – is implicated in promoting cell adhesion, spreading
and stabilization of basement membranes (Kohfeldt et al.,
1998). However, p200 might also represent a protein complex
formed by stable association of different extracellular matrix
proteins, such as the shed collagen XVII-ectodomain and
laminin 332-fragments (Tasanen et al., 2004).
In this study, we report three new cases of anti-p200
pemphigoid, which prompted us to investigate the nature of
p200 in detergent extracts of cultured epidermal cells and
fibroblasts and by IF on normal and genetically altered skin.
In addition, we assessed whether the 200 kDa basement
membrane constituent nidogen-2 shares identity with the
autoantigen of anti-p200 pemphigoid.
RESULTS
Patients P1, P2, and P3 display IF and western blot findings
indicating the diagnosis of anti-p200 pemphigoid
Tissue-bound autoantibodies were detected at the basement
membrane zone by direct IF in all three patients (Figure 1d). P1
and P3 revealed circulating IgG-autoantibodies binding to the
dermal side of the blister by indirect IF on salt-split-skin, serum
of P2 was unreactive by indirect IF. Although all patients
displayed circulating autoantibodies binding exclusively to a
200 kDa protein in keratinocyte extracts, only serum of P1
labeled p200 in immunoblots of dermal extracts (kindly
performed by Drs D. Zillikens and I. Shimanovich, Depart-
ment of Dermatology, University of Lu¨beck, Germany).
Circulating autoantibodies in anti-p200 pemphigoid recognize a
distinct 200 kDa protein from cultured keratinocytes and
fibroblasts
In order to improve the solubility and integrity of basement
membrane proteins, we extracted primary and immortalized
cultured epidermal cells and fibroblasts with a buffer
containing NP-40 as a detergent, EDTA to dissociate
Caþ þ -dependent protein–protein interactions, and a broad
spectrum of proteinase inhibitors. When the cells were
extracted without EDTA, anti-p200 pemphigoid sera showed
– in contrast to BP sera – no reactivity in immunoblots.
However, in immunoblots with EDTA containing extracts, the
sera reacted strongly and consistently with a protein of about
200 kDa derived from primary human keratinocytes (Figure
2a). To confirm the specific reactivity of anti-p200 sera with
epidermal cell extracts, we additionally used HaCaT kerati-
nocytes and SCC-25 cells for western blotting (Figure 2b).
The three new anti-p200 pemphigoid sera recognized
p200 not only in keratinocyte extracts but also in extracts of
cultured fibroblasts (Figure 2c). To assess secretion of p200 in
cell cultures, we processed extracts and media separately for
immunoblotting. Although anti-p200 sera did not detect
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Figure 1. Patient P1 displays clinical, histological, and IF findings
compatible with anti-p200 pemphigoid. (a and b) Clinically, the patient
presented with disseminated small blisters and erosions. (c) Hematoxy-
lin-eosin-stained histology demonstrated subepidermal blistering with a
mixed inflammatory infiltrate (bar¼ 100mm) and (d) direct IF using a
FITC-labeled antihuman C3 antibody (DAKO) showed linear C3 deposits
at the dermal–epidermal junction (bar¼50 mm).
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Figure 2. P200 is expressed by keratinocytes and fibroblasts in vitro.
(a) The extractability of p200 is dependent on the presence of EDTA in
contrast to collagen XVII. Extracts of normal human keratinocytes (KE)
were prepared in the presence (þ ) or absence () of EDTA, subjected to 7%
SDS-PAGE under reducing conditions and immunoblotted with anti-p200
pemphigoid serum and a well-characterized BP serum containing
autoantibodies to 180 kDa-collagen XVII. Migration positions of molecular
weight marker (kDa) are shown on the left. (b) p200 is expressed by primary
and immortalized keratinocytes. Extracts from normal human keratinocytes
(KE), HaCaT keratinocytes (HE), and SCC-25 cells (SE) were assessed for the
presence of p200 and the BP-autoantigen collagen XVII. (c) p200 is present in
extracts of fibroblasts. Extracts of keratinocytes (KE) and fibroblasts (FE), and
conditioned medium of keratinocytes (KM) and fibroblasts (FM) were reacted
with anti-p200 sera P1–P3 and a BP serum. Sera of patients P1–P3 recognized
p200 in extracts of keratinocytes and fibroblasts (black arrow) and a 170
kDa-band in fibroblast medium (white arrow). In fibroblast medium, some
additional weak bands are also visible, the identity and specificity of which
remains unknown at present. As expected, the BP serum reacted with
180 kDa-collagen XVII (black arrowhead) and its shed 120 kDa ectodomain
(white arrowhead), but did not display immunoreactivity with fibroblast
extracts or medium. Additional controls with normal human sera did not
show reactivity with keratinocytes or fibroblasts (not shown).
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proteins in the medium of epithelial cells, a band of about
170 kDa was labeled in the culture medium of fibroblasts by
patients P1, P2, and P3. BP sera, which were used as controls,
recognized collagen XVII in extracts of primary keratinocytes
and its shed soluble ectodomain in the medium. They
were devoid of reactivity with fibroblast extracts or medium
(Figure 2c). Normal control sera did not show any specific
reactivity.
Interestingly, p200 could only be visualized in immuno-
blots, if the SDS-PAGE was run under reducing conditions. If
dithiothreitol as a reducing agent was omitted, p200 was not
detectable.
Immunoblot analysis of human keratinocyte extracts with
an SDS-PAGE 4.5–15% gradient gel with anti-p200 sera
revealed exclusively a protein band that migrated between
BP230 (230 kDa) and collagen XVII (180 kDa), corresponding
to an apparent molecular weight of 200 kDa. As shown in
Figure 3, this position is clearly distinct from collagen VII,
BP230, collagen XVII, and laminin 332. Normal sera showed
no specific reactivity.
The biochemical properties of keratinocyte-derived p200 are
identical with those of dermal p200
As p200 has been characterized so far only in dermal extracts
(Shimanovich et al., 2003), we compared the biochemical
characteristics of cell culture-derived p200 to those reported
for dermis-derived p200 by limited enzyme digestions
(Figure 4). As delineated above, only EDTA-containing cell
extracts contained the protein of interest. Therefore, before
digestion with highly purified bacterial collagenase, a
calcium-dependent protease, EDTA was removed from the
cell extracts by ethanol precipitation. Similarly to the findings
of Shimanovich et al. (2003) on p200 in dermal extracts,
p200 from keratinocyte extracts resisted collagenase treat-
ment. Collagen VII, which was used as a positive control, was
cleaved to yield the non-collagenous NC1-domain, whereas
collagenase digestion of collagen XVII has been previously
shown by our laboratory to result in a fragment of about
65 kDa corresponding to the endodomain (Scha¨cke et al.,
1998). Trypsin digestion of keratinocyte extracts completely
abolished reactivity with anti-p200 sera. As a positive
control, collagen XVII was used, which was cleaved to yield
the trypsin resistant triple-helical fragment of about 90 kDa
(Franzke et al., 2004). Deglycosylation with N-glycosidase F
resulted in a small increase in the electrophoretic mobility of
p200, similarly to collagen XVII, indicating the presence of
N-linked sugar moieties in both proteins. Comparison of the
relative electrophoretic mobility before and after N-glycosi-
dase F digestion suggested that the molecular mass of
deglycosylated p200 was about 5,000 Da smaller than that
of the cell-derived protein.
P200 is not destabilized by lack of collagen XVII, collagen VII,
or laminin 332 from the dermal–epidermal junction
By indirect IF on 1 M salt-split-skin, circulating anti-p200
autoantibodies localized to the dermal side of the split at a
titer of 1:20, in contrast to BP autoantibodies, which bound to
the epidermal side of the blister (Figure 5a and e). A genetic
approach was taken for further characterization using skin
from epidermolysis bullosa (EB) patients lacking collagen VII,
collagen XVII, or laminin 332. In all cases, anti-p200
pemphigoid serum generated a positive signal. In junctional
EB (JEB) skin, which has a lamina lucida split, p200 was
localized at the dermal side of the blister. Conversely, in
dystrophic EB with a sub-lamina densa split, p200 was on the
epidermal side, indicating association with the lamina densa
of the basement membrane (Figure 5b–d and f–h).
Despite colocalization p200 is distinct from nidogen-2
As nidogen-2 is a known 200 kDa component of the lamina
densa of the cutaneous basement membrane, we assessed the
p200
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Figure 3. Keratinocyte-derived p200 is distinct from the major basement
membrane proteins. Keratinocyte extracts were separated on a 4.5–15%
gradient gel and transferred to nitrocellulose, which was subsequently
incubated with NC1F3 antibodies to collagen VII (290 kDa, lane 1), BP serum
containing autoantibodies to BP230 (230 kDa, lane 2) or collagen XVII
(180 kDa, lane 3), the 9LN5 antibody to the a3-chain of laminin 332
(165 kDa, lane 4), serum of P1 (lane 5), and a normal human serum (lane 6).
The antibodies were visualized by alkaline phosphatase-conjugated
anti-rabbit or anti-human IgG. The migration positions of molecular
weight markers (kDa) are indicated on the left.
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Figure 4. Keratinocyte-derived p200 is an N-glycosylated non-collagenous
protein. (a) Collagenase digestion. The untreated (lane 1 and 3) and digested
keratinocyte extract (lane 2 and 4) was immunostained with anti-p200 serum
P1 (lane 1 and 2) and the NC1F3-antibody to collagen VII (lane 3 and 4).
Although p200 was collagenase resistant, collagen VII was cleaved to yield
the 145 kDa non-collagenous NC1-domain. Collagenase digestion of
collagen XVII has been previously published by us and yielded a fragment
of about 65 kDa corresponding to the endodomain (Scha¨cke et al., 1998).
(b and c) Trypsin and N-glycosidase F digestion. Immunoreacitivity of
anti-p200 serum P1 (lane 1, before digestion; lane 2, after digestion) was
compared with a BP-serum containing autoantibodies against collagen
XVII (lane 5, before digestion; lane 6, after digestion). Trypsin digestion of
keratinocyte extracts completely abolished reactivity with anti-p200 sera,
in contrast to collagen XVII, which was cleaved to the trypsin resistant
triple-helical fragment of about 90 kDa (Franzke et al., 2004). Deglycosylation
with N-glycosidase F resulted in a small increase in the electrophoretic
mobility of p200, similarly to collagen XVII.
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precise location of p200 in relation to nidogen-2. As shown
in Figure 5, nidogen-2 colocalizes with p200 within the
dermal–epidermal junction zone. However, in addition to the
junctional staining, nidogen-2 antibody exhibited reactivity
with dermal blood vessels. Unfortunately, sera P1, P2, and P3
did not crossreact with normal murine skin, hindering a
genetic approach using nidogen-1 or nidogen-2 knockout
mouse skin. Electrophoretic co-migration of p200 and
nidogen-2 was demonstrated in immunoblots with human
fibroblast extracts as antigen (Figure 6a). However, none of
the three anti-p200 sera (P1–P3) showed reactivity with
recombinant human nidogen-2, indicating that it is distinct
from p200 (Figure 6b).
DISCUSSION
In this study, the diagnosis of anti-p200 pemphigoid in three
new patients was based on typical clinical, histological, and
IF findings, and on specific reactivity with a 200 kDa-protein
in immunoblots (Zillikens et al., 1996). All previous
investigations have shown that anti-p200 sera react with
dermal extracts. In particular, p200 was usually not detected
in cell extracts or conditioned medium of cultured keratino-
cytes and fibroblasts (Shimanovich et al., 2003). An
epidermal cell origin of p200, at least in vitro, is only
supported by one report showing immunoreactivity of anti-
p200 pemphigoid serum with a 200 kDa-protein in the
medium of SCC-25 cells (Zillikens et al., 1996).
The contradiction with the present findings prompted us to
investigate the immunoreactive 200 kDa protein in keratino-
cyte extracts in more detail and to compare it with p200
reported in the literature. First, we analyzed immortalized
keratinocyte cell lines (HaCaT keratinocytes and SCC-25
cells) in addition to primary human keratinocytes to confirm
the expression of p200 by keratinocytes. Second, thorough
investigation of the biochemical properties of keratinocyte-
derived p200 using limited proteolysis with collagenase and
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Figure 5. p200 is distinct from collagen XVII, collagen VII, or laminin 332 and colocalizes with nidogen-2. (a, e, i) For indirect IF, a representative BP
serum with autoantibodies to BP230 and collagen XVII, anti-p200 pemphigoid serum P1 and polyclonal nidogen-2 antibodies were incubated with sections
of normal human salt-split-skin (SSS), (b, f, j, m) lesional skin of a patient with dystrophic EB Hallopeau–Siemens, (c, g, k, n) lesional skin of a patient with
Herlitz JEB, (d, h, l, o) and lesional skin of a patient with non-Herlitz JEB. (m) The absence of collagen VII, (n) laminin 332, and (o) collagen XVII from the skin
was verified by antibodies LH 7.2 to the NC1-domain of collagen VII, BM165 to human laminin a3 chain, and ColXVII-NC16a to human collagen XVII,
respectively (controls). Immunoreactivity was visualized with FITC-conjugated antihuman IgG4, anti-rabbit IgG or anti-mouse IgG. BP autoantibodies bind to
the epidermal side of the split in all specimens. Anti-p200 serum and nidogen-2 antibodies label the dermal side of the blister in JEB and the epidermal side
in dystrophic EB (bar¼50 mm).
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Figure 6. Nidogen-2 is distinct from p200. (a) Fibroblast extracts (FE) were
separated by 7% SDS-PAGE and assayed for immunoreactivity with anti-p200
serum and polyclonal nidogen-2 antibodies (Nd-2). Both antibodies recognize
a protein of identical size. (b) To verify whether nidogen-2 is the candidate
autoantigen of anti-p200 pemphigoid, 5 mg of recombinant human nidogen-2
were immunoblotted with anti-p200 sera. Comparison of the reactivities of
anti-p200 sera and nidogen-2 antibodies shows that p200 is distinct from
nidogen-2. The migration positions of molecular weight markers (kDa) are
indicated on the left.
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trypsin, and removal of N-linked sugar moieties showed that,
similarly to dermal p200 (Shimanovich et al., 2003),
keratinocyte-derived p200 is an N-glycosylated protein
devoid of collagenous domains. Thus, it can be assumed
that p200 from either source is identical.
The detection of p200 in cell extracts may largely depend
on the extraction protocol applied. In contrast to previous
reports, we omitted pulse-sonication, but used NP40 as a
detergent, and a broad spectrum of protease inhibitors to
prevent degradation more efficiently (Scha¨cke et al., 1998;
Shimanovich et al., 2003). Our finding that efficient extrac-
tion of p200 depends on the presence of EDTA suggests that
p200 forms Caþþ -dependent protein–protein complexes,
similar to the laminin-nidogen complex (Paulsson et al.,
1987; Blauvelt et al., 1995), or forms complexes with
membrane associated proteins, similar to cadherins (Amagai
et al., 1995).
In previous studies, successful extraction of p200 from the
dermis was dependent on high concentrations of reducing
agents (Shimanovich et al., 2003). Here, we show that
reducing agents are not required for isolation of p200 from
cell cultures. However, comparative immunoblot analysis of
cell extracts under reducing and non-reducing conditions
demonstrated that p200 is only recognized by anti-p200 sera
under reducing conditions. This is in line with the hypothesis
of Shimanovich et al. (2003) that p200 forms large disulfide-
bonded aggregates either as a multimeric protein or together
with other components of the basement membrane zone. The
disulfide bonds in p200 are either intramolecular, or
intermolecular with other proteins extractable with the
present protocol, as p200 can be extracted from the cell
layer in the absence of reducing agents. It is conceivable that
some anti-p200 sera may contain autoantibodies against
labile epitopes destroyed or modified by the harsh extraction
methods used previously. This could also explain why two of
the new anti-p200 pemphigoid patients were devoid of
reactivity with p200 from dermal extracts.
Several components of the cutaneous basement mem-
brane zone, including collagen IV and collagen VII, laminin
111 (laminin 1), and fibronectin, are synthesized by
keratinocytes and fibroblasts (O’Keefe et al., 1985; Lee and
Cho, 2005). Therefore, we determined whether anti-p200
sera displayed immunoreactivity with extracts and media of
both cell types. Our data demonstrate that p200 is produced
in similar amounts by both, keratinocytes and fibroblasts, in
vitro. Furthermore, a protein of approximately 170 kDa was
detected by all three sera in conditioned medium of
fibroblasts, possibly indicating that p200 is secreted and
cleaved in the culture medium. The lack of immunoreactive
protein in keratinocyte medium may be due to formation of
calcium-dependent insoluble aggregates, as the presence of
proteolytic enzymes and potential binding partners varies
between keratinocytes and fibroblasts. In general, the in vitro-
secretion of p200 would be in accordance with electron
microscopy showing that p200 is an extracellular protein
(Chen et al., 1996). However, we are aware that the 170-kDa
bands detected in fibroblast medium may also represent
nonspecific reactivity of polyclonal human sera.
The finding, that p200 is a disulfide-bonded protein,
prompted us to assess the relation of p200 with the shed
collagen XVII-ectodomain, which extends into the lamina
densa (Nonaka et al., 2000), engages in ligand interactions
with laminin 332 and could therefore be part of an antigenic
protein complex. Along with collagen VII- and laminin 332-
deficient skin (Zillikens et al., 2000; Liu et al., 2003), we used
skin of a patient with non-Herlitz JEB and defined COL17A1
mutations resulting in the complete loss of collagen XVII, for
IF staining with anti-p200 serum. The signals generated by
anti-p200 serum indicated that p200 is distinct and function-
ally independent from collagen XVII, collagen VII, and
laminin 332.
In addition to these well-characterized components of the
dermal–epidermal junction, nidogen-1 and nidogen-2 are
ubiquitous basement membrane proteins involved in stabili-
zation of basement membranes (Salmivirta et al., 2002; Bader
et al., 2005). We considered nidogen-2 as a candidate target
in anti-p200 pemphigoid, taking into account its predicted
molecular weight of 200 kDa, often accompanied by a
cleavage product of about 170 kDa (Kohfeldt et al., 1998).
Nidogen-2 is physiologically produced by fibroblasts, but
synthesis of nidogen-2 can also be observed in keratinocyte
cultures under certain conditions (El Ghalbzouri et al., 2005).
Immunomapping on normal and EB skin revealed that
nidogen-2 indeed colocalized with p200 within the dermal–
epidermal junction. However, in contrast to nidogen-2
antibodies, anti-p200 sera do not stain dermal vessel walls
(Zillikens et al., 1996). As this discrepancy could have been
explained by localization-dependent epitope variation, pos-
sibly due to post-translational modifications, we addressed
the question whether p200 is identical to nidogen-2 with
protein chemical analysis. Sera P1, P2, and P3 did not exhibit
reactivity with purified recombinant human nidogen-2,
suggesting that the autoantigen of anti-p200 pemphigoid
is distinct from nidogen-2. This is in line with the different
IF patterns generated with nidogen-2 antibodies and anti-
p200 sera.
The molecular identity of p200 remains elusive. IF studies
and immunoblotting experiments using purified recombinant
or native proteins as well as biochemical analyses of the
p200-protein have been employed to rule out a number of
basement membrane proteins as candidate autoantigens of
anti-p200 pemphigoid (Table 1). Other basement membrane
proteins with an approximate molecular weight of 200 kDa
comprise a6-integrin, the laminin g1-chain, and the laminin
b2-chain. The first mentioned proteins have been previously
excluded as autoantigens of anti-p200 pemphigoid due to
their epidermal localization or the lack of reactivity of anti-
p200 sera with recombinant laminin 111, respectively. In
contrast, the laminin b2-chain (190 kDa) is part of laminin
321 (laminin 7) and laminin 521 (laminin 11), both of which
are expressed in the upper lamina densa of the epidermal
basement membrane, but also in dermal vessels (McMillan
et al., 2006). Future studies should address the question,
whether the laminin b2-chain is identical to p200.
In conclusion, this study identifies p200 as an extracellular
matrix protein synthesized by keratinocytes and fibroblasts,
www.jidonline.org 91
SC Hofmann et al.
Anti-p200 Pemphigoid
which is distinct from major basement membrane compo-
nents, including collagen XVII and nidogen-2. P200 is
engaged in calcium-dependent complex formation and can
be extracted from cell cultures with detergents and metal
chelators. The present protocol for extraction of p200 from
cultured skin cells will on one hand enlarge the methods for
diagnosing anti-p200 pemphigoid and, on the other hand,
also provide helpful knowledge for further identification and
functional characterization of the elusive autoantigen in this
bullous disorder.
MATERIALS AND METHODS
Case reports
Patient 1: a 61-year-old male (P1), presented with a 6-week history
of a pruriginous vesiculobullous eruption. Clinical examination
revealed multiple small, tense blisters, and erosions on the lower
back and dorsal aspects of the arms (Figure 1a and b). Large,
hemorrhagic bullae at the palms and soles and extensive genital
erosions were noted. Histology revealed subepidermal blisters with
neutrophilic and eosinophilic infiltrates, and direct IF showed linear
IgG and C3 deposits at the dermal–epidermal junction (Figure 1c and
d). Circulating autoantibodies binding to the dermal side of 1 M salt-
split-skin were detected by indirect IF (titer 1:20) and to a 200-kDa
protein by western blot analysis of dermal extracts. The serum was
devoid of reactivity with the NC16a-domain of collagen XVII/BP180
by ELISA (Hofmann et al., 2002). These characteristic features
confirmed the diagnosis of anti-p200 pemphigoid. Treatment with
prednisolone and dapsone led to an improvement of skin lesions.
Interestingly, soon after the diagnosis of anti-p200 pemphigoid, the
patient developed severe and refractory acquired hemophilia, which
was treated by high-dose corticosteroids, protein A-immunoadsorp-
tion and rituximab in conventional doses. This therapeutic regimen
induced clinical and serological remission of anti-p200 pemphigoid.
Patient 2: a 45-year-old man (P2) was referred to our hospital
with a 1-year-history of recurrent pruriginous tense blisters on the
right lower leg, which healed without scarring. Otherwise, the
dermatological status was unremarkable. Histology showed sub-
epidermal blisters and a predominant neutrophilic infiltrate. Direct
IF demonstrated linear C3-deposits at the dermal side after splitting
with 1 M NaCl, whereas indirect IF and NC16a-ELISA were negative.
The patient’s serum recognized a 200-kDa protein by immunoblot-
ting with keratinocyte extracts. The disease remained stable over the
past 6 months with topical corticosteroid treatment.
Patient 3: in a young boy (P3) with recurrent blister formation,
direct and indirect IF and western blot with keratinocyte extracts
suggested the diagnosis of anti-p200 pemphigoid. The clinical
features and precise diagnostic workup of this patient will be
discussed elsewhere (Tru¨eb et al., in preparation).
Table 1. Candidate autoantigens of anti-p200 pemphigoid
Protein Method Result Reference
BP230 (230 kDa) IF on salt-split-skin P200 at dermal side, BP230 at
epidermal side
Zillikens et al., 1996
Collagen VII (290 kDa) IF on collagen VII-deficient skin P200 present Zillikens et al., 2000; Liu et al.,
2003
Immunogold electron
microscopy
P200 localized at lower lamina
lucida, collagen VII at (sub-)
lamina densa
Morris et al., 2002
Collagen XVII (180 kDa) IF on salt-split-skin P200 at dermal side, collagen
XVII at epidermal side
Zillikens et al., 1996
IF on collagen XVII-deficient skin P200 present This study
Collagenous proteins in general Collagenase digestion P200 collagenase resistant Shimanovich et al., 2003, this
study
Fibronectin (230 kDa) Immunoblot with purified protein P200 sera unreactive Shimanovich et al., 2003
Integrin a6b4 (125/30, 205 kDa) IF on salt-split-skin P200 at dermal side, integrin
a6b4 at epidermal side
Zillikens et al., 1996
Laminin 111 (400, 220, 210 kDa) Immunoblot with purified protein P200 sera unreactive Zillikens et al., 1996; Kawahara
et al., 2000
Laminin 332 (165, 140, 105 kDa) Immunoblot with purified protein P200 sera unreactive Zillikens et al., 1996; Kawahara
et al., 2000
IF on laminin 332-deficient skin P200 present Zillikens et al., 2000, this study
Laminin 311 (165, 220, 210 kDa) Immunoblot with non-reduced
SCC-25 medium
P200 sera unreactive Zillikens et al., 1996; Kawahara
et al., 2000
Nidogen-2 (200 kDa) Immunoblot with purified protein P200 sera unreactive This study
Perlecan/proteoglycans in
general
Heparitinase and chondroitinase
digestion
P200 devoid of chondroitin
sulfate and heparan sulfate
side chains
Shimanovich et al., 2003
92 Journal of Investigative Dermatology (2008), Volume 128
SC Hofmann et al.
Anti-p200 Pemphigoid
Cell extracts and conditioned medium
Primary human keratinocytes were isolated from skin biopsies and
grown in serum-free keratinocyte growth medium supplemented
with bovine pituitary extract and epidermal growth factor as
described (Scha¨cke et al., 1998). HaCaT keratinocytes (kindly
provided by NE Fusenig, German Cancer Research Center, Heidel-
berg, Germany) and SCC-25 cells, derived from a well-differentiated
tongue squamous cell carcinoma, were grown as described
previously (Boukamp et al., 1988; Marinkovich et al., 1992).
Fibroblasts were maintained in DMEM supplemented with
L-glutamine, 10% fetal calf serum and penicillin/streptomycin
(Gibco Invitrogen, Grand Island, NY). Before extraction, 50 mg/ml
L-ascorbate was added for 48 hours.
For protein extractions, cell layer and media were processed
separately as reported (Scha¨cke et al., 1998). Confluent cell layers
were extracted for 30 minutes on ice with 1 ml/75 cm2 of a buffer
containing 1% NP-40, 0.1 M NaCl, 20 mM Tris-HCl (pH 7.5), 1 mM
Pefabloc (Merck, Darmstadt, Germany), and, when appropriate,
4 mM EDTA, 14 mg/ml chymostatin, 7mg/ml antipain, 7 mg/ml
leupeptin, and 14 mg/ml pepstatin. The cell lysate was then scraped
off with a rubber policeman, centrifuged at 14,000 g for
30 minutes at 41C and stored at 801C until use.
After a 48-hour incubation in serum-free medium, the culture
supernatant was collected on ice and 1 mM Pefabloc and 4 mM EDTA
were added immediately before centrifugation at 13,000 g for
10 minutes at 41C. Proteins were precipitated with chloroform-
methanol, centrifuged at 15,000 g for 10 minutes at 41C and pellets
were dissolved in SDS-PAGE buffer. Protein concentrations were
determined using a modified Lowry protocol (DC Protein Assay, Bio-
Rad, Munich, Germany) and 30 mg/ml of total protein were loaded
onto SDS-PAGE.
Proteolytic digests
For collagenase digestion, keratinocyte extracts were precipitated
with 70% ethanol and resuspended in collagenase buffer (0.05 M
Tris-HCl, 0.65 M NaCl, pH 7.4), 15 mM CaCl2, 1 mM Pefabloc (Merck,
Darmstadt, Germany), and 1.5 mM N-Ethylmaleimide. 1 U of
chromatographically purified collagenase form III from Clostridium
histolyticum (WAK-Chemie Medical GmbH, Bad Soden, Germany)
was added to 35 mg of protein. After incubation at 371C for 4 hours,
the reaction was stopped by adding 8 mM EDTA. For trypsin
digestion, cell lysates were incubated for 1 minute at 401C and snap
cooled on ice. 1 U of trypsin (Sigma, Saint Louis, MO) was added to
35 mg of cellular proteins and digested for 2 minutes at room
temperature (Olague-Marchan et al., 2000). The reaction was
stopped by adding soybean trypsin inhibitor (Sigma) to a final
concentration of 10 mg/ml.
For deglycosylation, 35 mg of protein extracts were treated with
5% SDS and 0.4 M dithiotreitol for 10 minutes at 601C before
digestion with 5 U PNGase F (New England Biolabs, Ipswich, MA)
for 1 hour at 371C. Undigested and digested samples were subjected
to 10% SDS-PAGE and after transfer on nitrocellulose incubated
with anti-p200 sera, BP sera or NC1F3 antibodies directed against
the NC1-domain of collagen VII (Mecklenbeck et al., 2002).
Immunoblot analyses
As antigens, extracts of primary and HaCaT keratinocytes, SCC cell
lines and fibroblasts, and recombinant human nidogen-2 were
employed. When necessary, the protein extracts were concentrated
by precipitation with 70% ethanol at 201C overnight before
separation by SDS-PAGE (7% or 4.5–15% gradient gels) under non-
reducing or reducing conditions. Recombinant human nidogen-2
was produced in human EBNA-293 cells and purified as described
(Kohfeldt et al., 1998). For immunoblotting, 0.25–5 mg of recombi-
nant protein were separated on a 7% SDS-PAGE gel under reducing
conditions. Human sera were diluted 1:20–1:100 and the anti-
nidogen-2 antiserum 1:2,000 (Kohfeldt et al., 1998). As controls,
antibody NC1F3 to collagen VII at a dilution of 1:1,000 (Mecklen-
beck et al., 2002) and antibody 9LN5 to the a3-chain of laminin 332
at a dilution of 1:2,000 were used. Incubations with primary
antibodies were overnight at 41C and with alkaline phosphatase-
labeled-anti-human or anti-rabbit IgG (Sigma) diluted 1:30,000
and 1:10,000, respectively, were for 2 hours. Immunoreactivity
was visualized using NBT/BCIP (Roth, Karlsruhe, Germany) as a
chromophore.
Indirect IF
Immunomapping of the dermal–epidermal junction was performed
on 8 mm cryosections of salt-split normal human skin, skin of EB
patients with defined mutations and skin of wild type and nidogen
knockout mice. Anti-p200 sera, a BP-serum reactive with collagen
XVII and BP230, and normal human serum were used in a 1:20
dilution. As controls, the following antibodies were employed: anti-
nidogen-2 antibodies (diluted 1:100) (Kohfeldt et al., 1998), ColXVII-
NC16a to human collagen XVII (Schumann et al., 2000), BM165 to
human laminin a3 chain (a kind gift from Dr P. Rousselle, Lyon,
France (Rousselle and Aumailley, 1994)), and 6F12 to human
laminin b3 chain (a kind gift from Dr R.E. Burgeson, Cutaneous
Biology Research Center, Harvard Medical School, Cambridge, MA,
USA), GB3 to laminin g2 chain (a generous gift of Dr G. Meneguzzi,
Nice, France (Meneguzzi et al., 1992)), LH 7.2 to the NC1-domain of
collagen VII (Sigma) and antibodies raised against the triple helical
domain of collagen VII (Hammami-Hauasli et al., 1997). Immuno-
reactivity was detected using FITC-conjugated monoclonal anti-
bodies to human IgG4 at a dilution of 1:60 (clone HP-6025,
Sigma), FITC-conjugated anti-rabbit IgG diluted 1:30 or FITC-
conjugated anti-mouse IgG diluted 1:40 (both DAKO, Glostrup,
Denmark).
Skin specimens with deficiency of a defined protein were
obtained from patients with non-Herlitz JEB with a homozygous
deletion 2560–2563delAATT in the COL17A1 gene (Vaisanen et al.,
2005), Herlitz JEB with a homozygous R42X-mutation in the LAMB3
gene (Kivirikko et al., 1996), dystrophic EB Hallopeau–Siemens with
compound heterozygous mutations c.425A4G and c.5261dupC in
the COL7A1 gene (Gardella et al., 1996; Kern et al., 2006), or from
knockout mice with targeted ablation of nidogen-1 or nidogen-2
(Murshed et al., 2000; Schymeinsky et al., 2002). The complete
absence of the mutated proteins was verified using the antibodies
listed above. This study was approved by the medical ethical
committee of the University Medical Center Freiburg, Germany.
Written informed consent was obtained from all patients whose
material was used in this study, in adherence to the Declaration of
Helsinki Principles.
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